Skip to content Skip to footer

Trillium-Krebsmedizin

ISSNs: 2198-9818

Trillium GmbH, Grafrath, Germany

Journal

Titles
  • Trillium-Krebsmedizin(2014 → …)
ISSNs2198-9818
PublisherTrillium GmbH, Grafrath
Country/TerritoryGermany
ZDB-ID3115244-2

Keywords

Library keywords

Related content

Operables Melanom: Neoadjuvante Immuntherapie – eine vielversprechende Option

Gellrich, F. F., 4 Jun 2024, In: Trillium-Krebsmedizin. 33, 3, p. 192-197 6 p.

Research output: Contribution to journal › Research article › Contributed

View all research output (1)